Hyperfractionated radiotherapy for clinical stage II non-small cell lung cancer
- 1 May 1999
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 51 (2), 141-145
- https://doi.org/10.1016/s0167-8140(99)00032-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Medically inoperable lung carcinoma: The role of radiation therapySeminars in Radiation Oncology, 1996
- Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for Stage III nonsmall cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995
- Curative radiotherapy for technically operable stage I nonsmall cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Inoperable non-small cell lung cancer: A retrospective analysis of 427 patients treated with high-dose radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Radiation therapy for Stage I–III epidermoid carcinoma of the lungLung Cancer, 1992
- Survival after resection of stage II non-small cell lung cancerThe Annals of Thoracic Surgery, 1992
- Comparison of the radiation therapy oncology group and american joint committee on cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the radiation therapy oncology group protocol 83-11Cancer, 1991
- Curative radiotherapy of early operable non-small cell lung cancerRadiotherapy and Oncology, 1989